Literature DB >> 11929717

CEA producing primary hepatic carcinoid.

Soo Ryang Kim1, Susumu Imoto, Yoko Maekawa, Toshiyuki Matsuoka, Yoshitake Hayashi, Kenji Ando, Keiji Mita, Shigeyuki Shintani, Haeng Boo Kim, Kwansong Ku, Toshihiro Koterazawa, Katsumi Fukuda, Yoshihiko Yano, Miyuki Nakaji, Hirotsugu Ikawa, Toshiaki Ninomiya, Masatoshi Kudo, Ke Ih Kim, Midori Hirai.   

Abstract

Imaging studies of a hepatic tumor in a 53-year-old woman with elevated serum levels of neuron-specific enolase (NSE), carcinoembryonic antigen (CEA) and 5-hydroxyindole acetic acid (5HIAA) revealed a hypervascular tumor in the right lobe. Grossly, the brownish tumor was measured 13.5x12 cm with four daughter nodules. Microscopically, the majority of these columnar and round tumor cells had ribbon-or rosette-like patterns with the expression of neuroendocrine marker proteins, such as Grimelius, NSE, chromogranin A, and synaptophysin, and moderate expression of CEA but without the expression of cytokeratin nos 7,8,14,18,19 and OV-6; the minority had glandular patterns with a strong expression of CEA but without the expression of cytokeratin nos 7,8,14,18,19 and OV-6. Ultrastructurally, most tumor cells contained populations of electron-dense core granules ranging between 100 and 200 nm in diameter. After hepatectomy, serum CEA, NSE, and 5HIAA reverted to normal ranges and persisted for 19 months. These findings suggested that the diagnosis of primary hepatic carcinoid was tenable and that the tumor might derive from hepatic stem cells which acquired the additional nature of producing CEA without cytokeratins characteristic of hepatocytes or bile duct cells. Some molecular based approaches have attributed unique biological behavior and histogenesis to this carcinoid tumor.

Entities:  

Year:  2002        PMID: 11929717     DOI: 10.1016/s1386-6346(01)00146-2

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  4 in total

1.  Recurrence of primary hepatic carcinoid tumor in the remnant liver 13 yr after resection.

Authors:  Hiroyuki Nishimori; Kunihiko Tsuji; Noriyuki Miyamoto; Yasuo Sakurai; Shinya Mitsui; Jong-Hon Kang; Masafumi Yoshida; Masashi Nomura; Itokawa Fuminori; Hirotoshi Ishiwatari; Takahiro Matsunaga; Manabu Osanai; Akio Katanuma; Kuniyuki Takahashi; Yoshinori Anbo; Tomoshige Masuda; Nobuichi Kashimura; Toshiya Shinohara; Hiroyuki Maguchi
Journal:  Int J Gastrointest Cancer       Date:  2005

2.  [Primary neuroendocrine carcinoma of the liver. From carcinoid tumor to small-cell hepatic carcinoma: case reports and review of the literature].

Authors:  Z Balta; T Sauerbruch; A Hirner; R Büttner; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

3.  Hepatic resection and transplantation for primary carcinoid tumors of the liver.

Authors:  Stephen W Fenwick; Judith I Wyatt; Giles J Toogood; J Peter A Lodge
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

Review 4.  Primary Hepatic Neuroendocrine Tumor: What Do We Know Now?

Authors:  Benjamin Quartey
Journal:  World J Oncol       Date:  2011-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.